The prefilled syringe presentation offers a convenient administration option to healthcare professionals.

The FDA has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.

The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine ...

In a makeshift tent on a Gazan beach, three-month-old Muntaha's grandmother grinds up chickpeas into the tiniest granules she ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe ...

The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.

Stepan shared this clip of him trying his absolute best to help a helpless little soul. The morning started with a hungry stare and trembling whiskers. A weak hare, barely able to lift its head, ...

Trisomy 18 is normally fatal within weeks of birth. But some parents are getting more time — with surgeries, luck and an ...

WuXi XDC cited strong demand for antibody-drug conjugates, which are widely used in targeted cancer treatments, and for ...

The recalled product was sold in ALDI stores across NSW, the ACT, Victoria, Queensland, South Australia and Western Australia ...

The syringe removes the need to reconstitute separate vials prior to administration, which simplifies the vaccine administration process for healthcare professionals, GSK said Thursday. The existing ...